{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T16:46:18Z","timestamp":1784565978043,"version":"3.55.0"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Preexisting health conditions complicate post\u2013COVID condition diagnosis in children and adolescents, while the lack of standardized clinical phenotypes challenges its definition and epidemiological estimates. Prospective studies with robust methodologies are needed to minimize bias and confounders, yet they remain scarce in high-impact factor journals.<\/jats:p><\/jats:sec>Objective<\/jats:title>To review, characterize, and assess the methodology used in studies examining post\u2013COVID condition in children and pediatric populations in highly cited studies, which have greater visibility and are likely to be used in informing policy.<\/jats:p><\/jats:sec>Evidence Review<\/jats:title>Studies on PubMed and studies with high citations on Web of Science published through July 2024 were reviewed. Pediatric studies from journals with an impact factor of 5 or higher were included if they employed observational or risk-benefit designs. Studies were classified based on whether they included a SARS-CoV-2 test-negative control group or a non\u2013test-negative group, which included studies with either no comparator or a different type of comparator. Joanna Briggs Institute and Risk of Bias in Nonrandomized Studies of Exposures tools assessed the risk of bias.<\/jats:p><\/jats:sec>Findings<\/jats:title>Of 426 publications, 24 were analyzed; 9 studies (38%) used test-negative controls, while 15 studies (63%) did not (P<\/jats:italic>\u2009&amp;lt;\u2009.001). Among studies with test-negative groups, 4 (44%) used prospective cohort designs vs 5 (33%) studies without a test-negative group. Demographic reporting of post\u2013COVID condition cases varied. Sex was reported in 12 studies (50%), but the median (IQR) sample size was small (27 female patients [14-110]; 21 male patients [10-79]). Psychiatric history was often not reported (20 patients [83%]), as well as a lack of history of comorbidities (16 patients [67%]) or body mass index (15 patients [63%]). Among 9 test-negative control studies, 4 (44%) used matched control design, while only 1 (11%) accounted for confounders by sex-stratifying results.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>These findings highlight the need for rigorous study designs that minimize bias and confounding, ensuring a clearer definition of pediatric post\u2013COVID condition and its sequelae. Employing true test-negative matched controls is essential for distinguishing common symptoms and assessing risk factors, while standardizing demographic reporting strengthens comparability and ensures consistency in patient selection.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.29659","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:30:38Z","timestamp":1759246238000},"page":"e2529659","source":"Crossref","is-referenced-by-count":3,"title":["Methods of Pediatric Post\u2013COVID Condition Studies in High-Impact Journals"],"prefix":"10.1001","volume":"8","author":[{"given":"Mary","family":"Rozelle","sequence":"first","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyson","family":"Haslam","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California"},{"name":"Sanofi, Morristown, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Prasad","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California"},{"name":"now with Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California"},{"name":"now with US Food and Drug Administration, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"zoi250835r1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2024-067043K","article-title":"Characteristics of children ages 1-17 who died of COVID-19 in 2020-2022 in the United States.","volume":"154","author":"Dykstra","year":"2024","journal-title":"Pediatrics"},{"issue":"3","key":"zoi250835r2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062570","article-title":"Postacute sequelae of SARS-CoV-2 in children.","volume":"153","author":"Rao","year":"2024","journal-title":"Pediatrics"},{"issue":"3","key":"zoi250835r3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bmjebm-2023-112338","article-title":"How methodological pitfalls have created widespread misunderstanding about long COVID.","volume":"29","author":"H\u00f8eg","year":"2024","journal-title":"BMJ Evid Based Med"},{"issue":"18","key":"zoi250835r4","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMsb2408466","article-title":"Long covid defined.","volume":"391","author":"Ely","year":"2024","journal-title":"N Engl J Med"},{"key":"zoi250835r5","author":"Selvakumar","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"9","key":"zoi250835r6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S2352-4642(22)00154-7","article-title":"Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.","volume":"6","author":"Kikkenborg Berg","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"10","key":"zoi250835r11","first-page":"2127","article-title":"Methodological quality of case series studies: an introduction to the JBI critical appraisal tool.","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"zoi250835r12","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.108602","article-title":"A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E).","volume":"186","author":"Higgins","year":"2024","journal-title":"Environ Int"},{"key":"zoi250835r13","author":"Jarupan","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"zoi250835r14","author":"Asadi-Pooya","year":"2021","journal-title":"World J Pediatr"},{"key":"zoi250835r15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1363410","article-title":"Coagulation profile in hospitalized children with COVID-19: pediatric age dependency and its impact on long COVID development.","volume":"15","author":"Boyarchuk","year":"2024","journal-title":"Front Immunol"},{"issue":"10","key":"zoi250835r16","doi-asserted-by":"publisher","first-page":"522","DOI":"10.47102\/annals-acadmedsg.V52N10p522","article-title":"Long COVID prevalence, risk factors and impact of vaccination in the paediatric population: A survey study in Singapore.","volume":"52","author":"Li","year":"2023","journal-title":"Ann Acad Med Singap"},{"issue":"7","key":"zoi250835r17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s12519-024-00805-2","article-title":"Clinical-based phenotypes in children with pediatric post-COVID-19 condition.","volume":"20","author":"Noij","year":"2024","journal-title":"World J Pediatr"},{"key":"zoi250835r18","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101961","article-title":"Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study.","volume":"59","author":"Morello","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"6","key":"zoi250835r19","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.kint.2023.02.028","article-title":"Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children.","volume":"103","author":"Avramescu","year":"2023","journal-title":"Kidney Int"},{"issue":"10","key":"zoi250835r20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/jamapediatrics.2022.2800","article-title":"Clinical features and burden of postacute sequelae of SARS-CoV-2 infection in children and adolescents.","volume":"176","author":"Rao","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"4","key":"zoi250835r21","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S2352-4642(22)00004-9","article-title":"Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): a national, cross-sectional study.","volume":"6","author":"Kikkenborg Berg","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"zoi250835r22","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29662","article-title":"Clinical effectiveness of nirmatrelvir plus ritonavir on the short- and long-term outcome in high-risk children with COVID-19.","volume":"96","author":"Wu","year":"2024","journal-title":"J Med Virol"},{"issue":"9","key":"zoi250835r23","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S2352-4642(22)00154-7","article-title":"Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study.","volume":"6","author":"Kikkenborg Berg","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"3","key":"zoi250835r24","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221250","article-title":"Pulmonary dysfunction after pediatric COVID-19.","volume":"306","author":"Heiss","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"zoi250835r25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12916-023-03221-x","article-title":"Event rates and incidence of post-COVID-19 condition in hospitalised SARS-CoV-2 positive children and young people and controls across different pandemic waves: exposure-stratified prospective cohort study in Moscow (StopCOVID).","volume":"22","author":"Pazukhina","year":"2024","journal-title":"BMC Med"},{"issue":"9","key":"zoi250835r26","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsad126","article-title":"Risk of post-acute sequelae of SARS-CoV-2 infection associated with pre-coronavirus disease obstructive sleep apnea diagnoses: an electronic health record-based analysis from the RECOVER initiative.","volume":"46","author":"L Mandel","year":"2023","journal-title":"Sleep"},{"key":"zoi250835r27","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1081718","article-title":"Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19.","volume":"13","author":"Sommen","year":"2023","journal-title":"Front Immunol"},{"issue":"4","key":"zoi250835r28","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S2352-4642(22)00022-0","article-title":"Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.","volume":"6","author":"Stephenson","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"zoi250835r29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1177\/01410768211052589","article-title":"Vaccinating adolescents against SARS-CoV-2 in England: a risk-benefit analysis.","volume":"114","author":"Gurdasani","year":"2021","journal-title":"J R Soc Med"},{"issue":"1","key":"zoi250835r30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12916-022-02448-4","article-title":"Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12?months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID).","volume":"20","author":"Pazukhina","year":"2022","journal-title":"BMC Med"},{"issue":"10","key":"zoi250835r31","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/vaccines10101686","article-title":"Dysautonomia in children with post-acute sequelae of Coronavirus 2019 Disease and\/or vaccination.","volume":"10","author":"Buchhorn","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"zoi250835r32","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jadohealth.2023.05.022","article-title":"Youth mental health outcomes up to two years after SARS-CoV-2 infection Long-COVID or Long-Pandemic Syndrome: A retrospective cohort study.","volume":"73","author":"Bilu","year":"2023","journal-title":"J Adolesc Health"},{"key":"zoi250835r33","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.bbi.2024.05.001","article-title":"Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant).","volume":"119","author":"Foret-Bruno","year":"2024","journal-title":"Brain Behav Immun"},{"key":"zoi250835r34","article-title":"Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months.","volume":"25","author":"Pinto Pereira","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"9","key":"zoi250835r35","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S2352-4642(21)00196-6","article-title":"Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection.","volume":"5","author":"Buonsenso","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"issue":"6","key":"zoi250835r36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/RLI.0000000000001048","article-title":"Multiparametric cardiovascular MRI assessment of Post-COVID Syndrome in children in comparison to matched healthy individuals.","volume":"59","author":"Eckstein","year":"2024","journal-title":"Invest Radiol"},{"key":"zoi250835r37","author":"Osmanov","year":"2022","journal-title":"Eur Respir J"},{"issue":"4","key":"zoi250835r38","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s00431-023-05360-y","article-title":"Long COVID in pediatrics-epidemiology, diagnosis, and management.","volume":"183","author":"Toepfner","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"5","key":"zoi250835r39","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/INF.0000000000003502","article-title":"The challenge of studying long COVID: an updated review.","volume":"41","author":"Zimmermann","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"zoi250835r7","doi-asserted-by":"crossref","unstructured":"Zhang? Y, Romieu-Hernandez? A, Boehmer? TK, . Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults.? medRxiv. 2022;2022.12.18.22283646. Preprint published online December 2022. doi:10.1101\/2022.12.18.22283646","DOI":"10.1101\/2022.12.18.22283646"},{"key":"zoi250835r8","unstructured":"US Food and Drug Administration. Update: FDA authorizes first COVID-19 test for self-testing at home. Published 17 October 2020. Accessed July 28, 2025. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-fda-authorizes-first-covid-19-test-self-testing-home#:~:text=%2D19%20testing.%E2%80%9D-,The%20Lucira%20COVID%2D19%20All%2DIn%2DOne%20Test%20Kit,by%20their%20health%20care%20provider"},{"key":"zoi250835r9","unstructured":"WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus. Published 6 October 2021. Accessed July 28, 2025. https:\/\/iris.who.int\/bitstream\/handle\/10665\/345824\/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-eng.pdf?sequence=1&isAllowed=y"},{"key":"zoi250835r10","unstructured":"WHO. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus, Published 16 February 2023. Accessed July 28, 2025. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839486\/rozelle_2025_oi_250835_1758638244.41383.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:30:43Z","timestamp":1759246243000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839486"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.29659","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]}}}